2025-01-13 2026-01-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 16179354 bus:FullAccounts 2025-01-13 2026-01-31 16179354 bus:Micro-entities 2025-01-13 2026-01-31 16179354 bus:AuditExempt-NoAccountantsReport 2025-01-13 2026-01-31 16179354 bus:SmallCompaniesRegimeForAccounts 2025-01-13 2026-01-31 16179354 bus:PrivateLimitedCompanyLtd 2025-01-13 2026-01-31 16179354 2025-01-13 2026-01-31 16179354 2026-01-31 16179354 bus:RegisteredOffice 2025-01-13 2026-01-31 16179354 core:WithinOneYear 2026-01-31 16179354 core:AfterOneYear 2026-01-31 16179354 2024-01-13 16179354 bus:Director1 2025-01-13 2026-01-31 16179354 bus:Director1 2026-01-31 16179354 bus:CompanySecretary1 2025-01-13 2026-01-31 16179354 bus:LeadAgentIfApplicable 2025-01-13 2026-01-31 16179354 2025-01-12 16179354 core:ComputerEquipment 2025-01-13 2026-01-31 16179354 core:ComputerEquipment 2026-01-31 16179354 core:ComputerEquipment 2025-01-12 16179354 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-01-31 16179354 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-12 16179354 core:CostValuation core:Non-currentFinancialInstruments 2026-01-31 16179354 core:CostValuation core:Non-currentFinancialInstruments 2025-01-12 16179354 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-01-31 16179354 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16179354 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16179354 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16179354 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-01-31 16179354 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-01-31 16179354 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16179354 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16179354 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16179354 core:Non-currentFinancialInstruments 2026-01-31 16179354 core:Non-currentFinancialInstruments 2025-01-12 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 16179354
England and Wales

 

 

 


Unaudited Financial Statements

for the period ended 31 January 2026

for

CB BUSINESS ANALYSIS LIMITED

 
 
 
£
2026
£
Fixed assets 1,049 
Current assets 44,174 
Creditors: amount falling due within one year (30,138)
Net current assets/(liabilities) 14,036 
Total assets less current liabilities 15,085 
Net assets/(liabilities) 15,085 
 
Capital and reserves 15,085 
 



Notes to the Accounts
Statutory Information
Cb Business Analysis Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number 16179354, registration address 1 Birch Lane, Glenfield, Leicester, LE3 8HJ, England.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the period was 1.

Director's Responsibilities:
  1. For the period ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions.

Signed on behalf of the board of directors:


---------------------------------------------
Christopher Bruce
Director

Date approved: 23 July 2026
1